Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market Desonide Cream used in treating skin conditions with inflammation and itching in the American market. The company said it has received the final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Desonide Cream, 0.05 per cent.
Aleor's Generic Desonide Receives Approval in the U.S.
Aleor Dermaceuticals Generic Desonide Receives Approval in US
Teresina `s Generic Desonide Receives Approval in US
Cadila Healthcare's Generic Desonide Receives Approval in US
Aleor Dermaceuticals Generic Desonide Receives Approval in US
After more than a decade, LEO Pharma is getting a new chief executive as it looks to the future for a boosted pipeline and launches.
Teligent Pharma`s Generic Desonide Receives Approval in US
Encube Ethicals's Generic Desonide Receives Approval in US
Glenmark Pharm’s Generic Desonide Receives Approval In US